[Expert consensus on the diagnosis, treatment, and management of liver nodules (version 2026)] [0.03%]
[肝结节的诊断、治疗和管理专家共识（2026版）]
Infectious Diseases Prevention and Control Branch, Chinese Preventive Medicine Association
Infectious Diseases Prevention and Control Branch
Liver nodules are one of the common and complex clinical conditions, with certain ones developing into malignant lesions, hence significantly affecting patient prognosis. The detection rate of liver nodules has significantly improved with a...
[Expert consensus on overall standardized management of gadoxetate disodium-enhanced MRI examinations (version 2026)] [0.03%]
[ gadobenate二钠增强MRI检查全流程规范化管理专家共识(2023年版)]
Abdomen Group of Chinese Society of Radiology, Chinese Medical Association;Nursing Group of Chinese Society of Imaging Technology, Chinese Medical Association;Chongqing Society of Radiology et al.
Abdomen Group of Chinese Society of Radiology et al.
Gadoxetate disodium (Gd-EOB-DTPA), as a hepatocyte-specific MRI contrast agent, plays a key role in the early-stage diagnosis, differential diagnosis, and treatment evaluation of liver diseases. Gd-EOB-DTPA-enhanced MRI has been recommended...
[Chinese expert consensus on the use of standardized second-line drugs for primary hepatocellular carcinoma] [0.03%]
中国原发性肝癌经动脉化疗栓塞治疗后应用标准化二线药物治疗专家共识
Translational Medicine Branch, China Association of Gerontology and Geriatrics;Society of Hepatology, Beijing Medical Association;Expert Committee on Liver Cancer et al.
Translational Medicine Branch et al.
With the rapid development of systemic therapy for primary hepatocellular carcinoma, how to scientifically formulate subsequent treatment strategies following first-line treatment failure has become a key issue that urgently needs to be add...
[Expert consensus on the management process within medical institutions for patients with hepatitis B virus infection] [0.03%]
《乙型肝炎病毒患者院内管理流程专家共识》
Author Group of Expert Consensus
Author Group of Expert Consensus
In order to effectively utilize hepatitis B information obtained during routine health checkups, a panel of experts from clinical medicine, public health, laboratory testing, and methodology reviewed the latest research findings in guidelin...
S Tang,W Hou,Z P Duan et al.
S Tang et al.
Y Zhi,Y N Dong,X H Lei et al.
Y Zhi et al.
[Research advances in autoimmune liver disease in 2025: toward precision regulation and personalized treatment] [0.03%]
2025年自身免疫性肝病研究进展：迈向精准调控与个性化治疗
Y L Shang,Y Han
Y L Shang
[Clinical research progress in 2025 for hepatic fibrosis, cirrhosis, and portal hypertension] [0.03%]
[2025年肝纤维化、肝硬化和门脉高压症临床研究进展]
Y F Han,X Y Xu
Y F Han